In a research report published Friday, MLV analyst Vernon Bernardino reiterated a Buy rating on Conatus Pharmaceuticals Inc (NASDAQ:CNAT) with a $16 price target, …
MLV’s healthcare analyst Vernon Bernardino came out with a few insights on Dynavax Technologies Corporation (NASDAQ:DVAX), after the company’s independent Data and Safety Monitoring Board (DSMB) has …
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) shares were on the rise Friday after an upgrade from MLV’s analyst Vernon Bernardino.
In a research report published Thursday, MLV analyst Vernon Bernardino maintained a Buy rating on Galena Biopharma (NASDAQ:GALE) with a $5 price target, following …
MLV analyst Vernon Bernardino weighed in today with a few insights on Conatus Pharmaceuticals (NASDAQ:CNAT), following discussions with management during the J.P.
MLV analyst Vernon Bernardino weighed in today with a few insights on Galena Biopharma (NASDAQ:GALE), following discussions with management during the J.P.
MLV’s healthcare analyst Vernon Bernardino is weighing in with some thoughts on Conatus Pharmaceuticals (NASDAQ:CNAT), as the company reported aggregated topline results from phase 1 and 2 studies with …
In a research report published today, MLV analyst Vernon Bernardino reiterated a Buy rating on shares of Galectin Therapeutics (NASDAQ:GALT) with a $16 price target, following final …
MLV’s healthcare analyst Vernon Bernardino today weighed in with his thoughts on several stocks, which have promising candidates in clinical development for liver diseaes, following the news …
In a research report issued today, MLV analyst Vernon Bernardino maintained a Buy rating on Conatus Pharmaceuticals (NASDAQ:CNAT) with a $16 price target, ahead …
